
The Society
More than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS community
Become an ERS member

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Other cookies are those that are being identified and have not been classified into any category as yet.
The International Multicentre Pleural Research Collaborative was established as a CRC in 2016, known then as the International Collaborative Effusion Database (ICE db).
The collaboration was created by Rahul Bhatagar, Julius Jansen, and Nick Maskell, to bring pleural medicine experts and clinicians together to pool data on rare and neglected pleural diseases.
In the first phase, IMPACT (previously ICE db) created the largest international datasets on non-specific pleuritis, eosinophilic effusions, benign effusions, and chylothorax to date. Under the leadership of the new chairs since 2022, the second phase of IMPACT has an expanded mandate which includes pleural infection, pleural procedures, pleural fluid biomarkers, and other topics selected by the membership.
The vision of the IMPACT is to provide an international platform for pleural disease research that has global clinical impact which is relevant to patients.
With this purpose, IMPACT aims specifically to:
1. Clinical characteristics of chylothorax: results from the International Collaborative Effusion (ICE) database https://openres.ersjournals.com/content/early/2023/08/17/23120541.00091-2023
Summary: First multi-centre study of chylothorax and its associated outcomes, involving 12 sites across 9 countries contributed anonymised data on 77 patients.
2. Investigation and outcomes in patients with non-specific pleuritis: Results from the International Collaborative Effusion (ICE) database https://openres.ersjournals.com/content/early/2023/01/05/23120541.00599-2022
Summary: First multi-centre study of non-specific pleuritis and its associated outcomes, involving 12 sites across 9 countries contributed anonymised data on 187 patients.
3. Clinical Characteristics of Non-Malignant Effusions: Results from the ERS International Collaborative Effusion (ICE) Database. DOI: 10.1183/13993003.congress-2023.PA4437 [manuscript under review].
4. Investigation and outcomes of eosinophilic effusions
Status: Database closed and locked. Currently being analysed.
5. Suspected drug-induced pleural effusions
Status: Database open for submission and for new sites, please contact: Jenny.Symonds@nbt.nhs.uk.
IMPACT will focus on the following topics in Phase 2:
1. Research priorities and clinical practice in pleural medicine: a survey of patients and global pleural experts.
2. Pleural infection: microbiology, interventions, antibiotics, intrapleural therapy and outcomes.
3. Secondary spontaneous pneumothorax: drainage systems, chest tubes, autologous blood patch pleurodesis for persistent air leaks: international practices and outcomes.
4. Pleural Malignancy: timing and choice of pleurodesis and indwelling pleural catheters, patients’ perspectives: international practices and outcomes.
5. Recurrent pleural effusion: diagnostic pathways, CT and PET-CT, new diagnostic biomarkers, biobank.
6. Enriching the retrospective ICE databases with prospective data.
IMPACT is composed of:
If you are interested in more information about the CRC IMPACT or would like to join the network, please contact jenny.symonds@nbt.nhs.uk